These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
57 related items for PubMed ID: 7808503
1. Deferoxamine in thalassemia major. Cazzola M, Locatelli F, De Stefano P. N Engl J Med; 1995 Jan 26; 332(4):271-2; author reply 272-3. PubMed ID: 7808503 [No Abstract] [Full Text] [Related]
3. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major. Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P. Ann N Y Acad Sci; 2005 Jan 26; 1054():429-32. PubMed ID: 16339692 [Abstract] [Full Text] [Related]
4. Deferoxamine in thalassemia major. Splendiani G, Tozzo C, Mazzarella V, Casciani CU. N Engl J Med; 1995 Jan 26; 332(4):270-1. PubMed ID: 7808501 [No Abstract] [Full Text] [Related]
5. Deferoxamine in thalassemia major. Lucarelli G, Clift R, Angelucci E. N Engl J Med; 1995 Jan 26; 332(4):271; author reply 272-3. PubMed ID: 7808502 [No Abstract] [Full Text] [Related]
9. Current trends in management of the beta thalassemias. Shah D, Choudhury P, Dubey AP. Indian Pediatr; 1999 Dec 26; 36(12):1229-42. PubMed ID: 10745364 [No Abstract] [Full Text] [Related]
10. Desferrioxamine therapy induces clearance of iron deposits after bone marrow transplantation for thalassemia: case report. Giardini C, La Nasa G, Contu L, Galimberti M, Polchi P, Angelucci E, Baronciani D, Barbanti I, Muretto P, Lucarelli G. Bone Marrow Transplant; 1993 Dec 26; 12 Suppl 1():108-10. PubMed ID: 8374548 [No Abstract] [Full Text] [Related]
11. [Measurement of the secretion of growth hormone in patients with thalassemia major]. De Luca G, Maggiolini M, Bria M, Caracciolo M, Lanzino M, Le Pera M, Brancati C, Andò S. Minerva Endocrinol; 1993 Sep 26; 18(3 Suppl 1):62-5. PubMed ID: 7910656 [No Abstract] [Full Text] [Related]
13. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine. Shamsian BS, Aminasnafi A, Moghadassian H, Gachkar L, Arzanian MT, Alavi S, Esfehani H, Garallahi F, Amini R. Pediatr Hematol Oncol; 2008 Sep 26; 25(6):502-8. PubMed ID: 18728969 [Abstract] [Full Text] [Related]
14. [Therapeuetic management of patients with thalassemia major]. Thuret I. Bull Soc Pathol Exot; 2001 May 26; 94(2):95-7. PubMed ID: 11475036 [Abstract] [Full Text] [Related]
15. Common queries in thalassemia care. Panigrahi I, Marwaha RK. Indian Pediatr; 2006 Jun 26; 43(6):513-8. PubMed ID: 16820660 [Abstract] [Full Text] [Related]
16. Transfusion-dependent beta thalassemia in Afghanistan: current evidence amid COVID-19 and future recommendations. Qaderi S, Mousavi SH, Ahmadi A, Arif S, Madadi S, Ayoubi S, Lucero-Prisno DE. Hematology; 2021 Dec 26; 26(1):432-434. PubMed ID: 34130618 [No Abstract] [Full Text] [Related]
17. Cardiac status in well-treated patients with thalassemia major. Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J, Mitilineou E, Diamanti-Kandaraki E, Meletis J, Karagiorga M. Eur J Haematol; 2004 Nov 26; 73(5):359-66. PubMed ID: 15458515 [Abstract] [Full Text] [Related]
18. Pregnancy and lactation in homozygous beta-thalassemia major. Surbek DV, Glanzmann R, Nars PW, Holzgreve W. J Perinat Med; 1998 Nov 26; 26(3):240-3. PubMed ID: 9773387 [Abstract] [Full Text] [Related]